TIDM19PK TIDMTTM TIDMCYBG

RNS Number : 9381N

Morgan Stanley & Co. Int'l plc

03 February 2016

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

CYBG PLC (the "Company")

Stabilisation Notice

03 February 2016

Morgan Stanley & Co. International plc (contact: Martin Thorneycroft: telephone: +44 (0) 20 7425 8000) hereby gives notice that the Stabilising Manager named below and its affiliates may stabilise the offer of the following securities in accordance with Commission Regulation (EC) No. 2273/2003 implementing the Market Abuse Directive (2003/6/EC).

 
 The securities: 
--------------------------------------------------------------- 
 Issuer:              CYBG PLC 
-------------------  ------------------------------------------ 
 Securities:          Ordinary shares ("Shares") of the 
                       Issuer (ISIN: GB00BD6GN03) 
                       CHESS Depositary Interests ("CDIs") 
                       if the Issuer (ISIN: AU000000CYB7) 
-------------------  ------------------------------------------ 
 Offer size:          191,155,491 Shares ("Offer Shares") 
                       (excluding the over-allotment option) 
-------------------  ------------------------------------------ 
 Offer price:         180 pence per Share 
-------------------  ------------------------------------------ 
 Stabilisation: 
--------------------------------------------------------------- 
 Stabilising          Morgan Stanley & Co. International 
  Manager:             plc, 25 Cabot Square, Canary Wharf, 
                       London E14 4QA 
-------------------  ------------------------------------------ 
 Stabilisation        03 February 2016 at 8:00 a.m. 
  period expected 
  to start on: 
-------------------  ------------------------------------------ 
 Stabilisation        4 March 2016 
  period expected 
  to end no later 
  than: 
-------------------  ------------------------------------------ 
 Maximum size         Up to 28,673,323 Shares 
  of over-allotment 
  facility: 
-------------------  ------------------------------------------ 
 Over-allotment Option: 
--------------------------------------------------------------- 
 Terms:               The Issuer has granted Morgan Stanley 
                       & Co. International plc, in its capacity 
                       as stabilisation manager, and for 
                       the account of the underwriters, the 
                       option to acquire up to an additional 
                       28,673,323 Shares at the Offer Price 
                       (representing up to 15 per cent of 
                       the Offer size). Any exercise of the 
                       Over-allotment Option may be settled 
                       by the Selling Shareholder in cash. 
-------------------  ------------------------------------------ 
 Duration:            This option may be executed at any 
                       time during the stabilisation period. 
-------------------  ------------------------------------------

In connection with the offer of the above securities, the Stabilising Manager may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilising Manager will take any stabilisation action and any stabilisation action, if begun, may be ended at any time.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

END

This information is provided by RNS

The company news service from the London Stock Exchange

END

STATJMMTMBMMBFF

(END) Dow Jones Newswires

February 03, 2016 05:08 ET (10:08 GMT)

Ve Bionic Etf (LSE:CYBG)
Historical Stock Chart
Von Jun 2024 bis Jul 2024 Click Here for more Ve Bionic Etf Charts.
Ve Bionic Etf (LSE:CYBG)
Historical Stock Chart
Von Jul 2023 bis Jul 2024 Click Here for more Ve Bionic Etf Charts.